You are here

Clinical Trials: Urological Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, March 13, 2018 - 12:00
Conditions:   Urologic Diseases;   Male Urogenital Diseases;   Penile Diseases;   Corpus Callosum Malformation;   Corpora Cavernosa; Inflammation;   Trauma Injury
Intervention:   Biological: Autologous tissue engineered corpora
Sponsors:   Wake Forest University Health Sciences;   United States Department of Defense
Not yet recruiting
Posted: Tuesday, February 20, 2018 - 12:00
Condition:   Urinary Stress Incontinence
Intervention:   Other: Muscle Precursor Cells (MPCs), ATMP
Sponsors:   University of Zurich;   University Hospital Tuebingen;   Salzburger Landeskliniken
Not yet recruiting
Posted: Monday, October 30, 2017 - 12:00
Conditions:   Chronic Kidney Diseases;   Diabetes Mellitus;   Diabetic Nephropathies
Interventions:   Dietary Supplement: Fisetin;   Drug: Placebo oral capsule
Sponsor:   Mayo Clinic
Posted: Thursday, October 26, 2017 - 12:00
Conditions:   Mesenchymal Stem Cells;   Chronic Kidney Diseases;   Renal Interstitial Fibrosis
Interventions:   Drug: Treatment group;   Drug: Control group
Sponsor:   The Affiliated Hospital of Xuzhou Medical University
Posted: Tuesday, August 8, 2017 - 12:00
Condition:   Diabetic Nephropathies
Intervention:   Biological: Wharton Jelly Mesenchymal stem cells
Sponsors:   Sophia Al-Adwan;   Jordan University of Science and Technology;   An-Najah National University
Not yet recruiting - verified September 2017
Posted: Thursday, August 3, 2017 - 12:00
Conditions:   Urologic Diseases;   Male Urogenital Diseases;   Urethral Stricture;   Urethral Injury
Intervention:   Biological: Autologous Engineered Urethral Construct
Sponsors:   Wake Forest University Health Sciences;   United States Department of Defense
Recruiting - verified August 2017
Posted: Monday, June 12, 2017 - 12:00
Conditions:   Renal Failure;   End Stage Renal Disease;   Hemodialysis;   Vascular Access
Interventions:   Biological: Human Acellular Vessel (HAV);   Procedure: Arteriovenous fistula (AVF)
Sponsors:   Humacyte, Inc.;   CTI Clinical Trial and Consulting Services;   California Institute for Regenerative Medicine (CIRM)
Posted: Monday, April 3, 2017 - 12:00
Condition:   Interstitial Cystitis
Intervention:   Biological: Platelet-Rich Plasma
Sponsor:   Buddhist Tzu Chi General Hospital
Not yet recruiting - verified April 2017
Posted: Friday, January 6, 2017 - 12:00
Condition:   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Posted: Thursday, October 13, 2016 - 12:00
Condition:   Moderate to Severe Chronic Kidney Disease
Intervention:   Drug: Elixcyte
Sponsors:   UnicoCell Biomed CO. LTD;   A2 Healthcare Taiwan Corporation
Not yet recruiting - verified October 2016